GW Pharmaceuticals PLC News - GWPH | Aktien NASDAQ | ADVFN

Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

GW Pharmaceuticals PLC (GWPH)

218,96

0,00

(0,00%)

Beim Schlusskurs: 04 Dezember 10:00PM

Verzögert um 15 Minuten

218,96

0,00

( 0,00% )

Nach Börsenschluss: -

Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on May 5, 2021 REGISTRATION NO. 333-204389 REGISTRATION...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on May 5, 2021 REGISTRATION NO. 333-204389 REGISTRATION...

Post-effective Amendment to an S-8 Filing (s-8 Pos)

As filed with the Securities and Exchange Commission on May 5, 2021 REGISTRATION NO. 333-204389 REGISTRATION...

Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)

As filed with the Securities and Exchange Commission on May 5, 2021 REGISTRATION NO. 333-229308 ...

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc

Jazz Pharmaceuticals Completes Acquisition of GW Pharmaceuticals plc PR Newswire DUBLIN, May 5, 2021 DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz...

Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File...

Quarterly Report (10-q)

false Q1 0001351288 --12-31 00-0000000 true true P5Y 0001351288 2021-01-01 2021-03-31 xbrli:shares 0001351288 2021-04-23 iso4217:...

Amended Annual Report (10-k/a)

trueFY0001351288YesYesYesNo00-0000000 0001351288 2020-01-01 2020-12-31 0001351288 2021-04-23 0001351288 2020-06-30 xbrli:shares...

GW Pharmaceuticals recognised for leadership in prescription cannabis-based medicines with prestigious Queen’s Award for En...

LONDON, April 29, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the...

Current Report Filing (8-k)

CB24 9BZ United Kingdom 00-0000000 false 0001351288 0001351288 2021-04-23 2021-04-23 UNITED...

GW Pharmaceuticals Shareholders Approve Acquisition by Jazz Pharmaceuticals

LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz...

Current Report Filing (8-k)

CB24 9BZ United Kingdom 00-0000000 false 0001351288 0001351288 2021-04-20 2021-04-20 UNITED...

Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

GW Pharmaceuticals receives European Commission approval for EPIDYOLEX® (cannabidiol) for the treatment of seizures associat...

– Tuberous sclerosis complex (TSC) represents a third indication for GW’s cannabidiol in Europe – – TSC causes...

1
2
Weiter

Foren

Keine Diskussionen Gefunden.

Neuen Thread Erstellen

GW Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen